Filter
400
Text search:
World
Health
Organization
WHO,
SAGE
Featured
Recommendations
41
New Publications
66
Language
Document type
No document type
140
Guidelines
97
Studies & Reports
62
Fact sheets
31
Manuals
25
Strategic & Response Plan
24
Training Material
8
Situation Updates
8
Brochures
2
Resource Platforms
2
Videos
1
Countries / Regions
Global
22
Latin America and the Carribbean
11
Russia
11
Congo, Democratic Republic of
10
Brazil
9
India
7
Syria
7
Western and Central Europe
7
Sierra Leone
6
Africa
6
Uganda
5
South Africa
5
Guinea
4
Ghana
4
Zambia
4
Tanzania
4
Lesotho
4
Middle East and North Africa
4
Burkina Faso
3
Liberia
3
Pakistan
3
South Sudan
3
Afghanistan
3
Rwanda
3
Ukraine
3
Yemen
3
Cameroon
2
Haiti
2
Philippines
2
Nepal
2
Malawi
2
Sudan
2
Colombia
2
Eastern Europe and Central Asia
2
Nigeria
1
Senegal
1
Saudi Arabia
1
Ethiopia
1
Somalia
1
Germany
1
Lebanon
1
Chad
1
Kenya
1
China
1
Bangladesh
1
Mozambique
1
Peru
1
Botswana
1
Angola
1
Myanmar / Burma
1
Chile
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Eastern Europe
1
Canada
1
Kazakhstan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
93
Clinical Guidelines
44
Women & Child Health
25
Public Health
23
Key Resources
12
Capacity Building
6
Pharmacy & Technologies
1
Toolboxes
COVID-19
137
Mental Health
26
Rapid Response
23
Polio
16
HIV
16
Disability
13
TB
13
Ebola
12
Planetary Health
10
Pharmacy
9
AMR
8
NTDs
8
NCDs
8
Caregiver
7
Global Health Education
6
Social Ethics
5
Refugee
4
Health Financing Toolbox
4
Conflict
3
Cholera
2
Natural Hazards
1
Zika
1
Specific Hazards
1
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (
...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE
...
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 29 JULY 2016, 91th YEAR / 29 JUILLET 2016, 91e ANNÉENo 30, 2016, 91, 349–364
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE
...
first issued 18 August 2022
El propósito de este marco de valores es brindar orientación a nivel mundial acerca de la asignación de las vacunas contra la COVID-19 entre los países y a nivel nacional con respecto a la determinación de los grupos prioritarios para recibirlas dentro de los países, mientras el suministro sea
...
This guidance describes the methods and processes of the Strategic Advisory Group of Experts (SAGE) on Immunization in developing evidence-based recommendations, WHO vaccine position papers, and oth
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vac
...
Вакцинация и доверие: Как возникает озабоченность и роль коммуникации в смягчении кризисных ситуаций
recommended
Когда возникают ситуации, при которых нежелательные явления справедливо или ошибочно связывают с вакцинацией, они могут подорвать доверие к вакцинам и официальны
...
Временное руководство, Первый выпуск 8 января 2021 г., Обновлено 15 июня 2021 г., Обновлено 19 ноября 2021 г.
How far apart should the doses of vaccines be? What if I miss my second dose? Can I get two doses from two different manufacturers? How was safety of vaccines ensured? WHO’s Chief Scientist, Dr Soumya Swaminathan explains in Science in 5.
Vaccination programmes against COVID-19 and seasonal influenza are currently being implemented in parallel in many countries. Administration of both vaccines during the same visit has potential advantages. This document presents the evidence related to coadministration of Covid-19 and influenza vacc
...
временные рекомендации от 8 января 2021 г.
Available in Arabic, Chinese, English, French, Russian and Spanish here: https://apps.who.int/iris/handle/10665/338484
